Russian COVID-19 Vaccine
Updated: 2025-04-04 Type: Write-up Factial: Undetermined Topics: Covid-19, (Post Id: #16)
Warning against Russian corona vaccine
There is a lack of data, there is a lack of transparency: The president of the Paul-Ehrlich-Institute, Cichutek, criticized the Russian approval of a corona vaccine in the “tagesthemen”. Experts and governments are also skeptical internationally.
The Paul Ehrlich Institute (PEI), which is responsible for the approval of vaccines in Germany, considers the use of the corona vaccine approved in Russia to be a risk. PEI President Klaus Cichutek said in the “tagesthemen” that Russian vaccine development has shortcomings. “It is necessary to collect statistically significant safety and efficacy data. This seems not to have been done with this vaccine.”
Cichutek is referring to the fact that Russian approval was granted before the completion of the third phase of testing the vaccine. This usually takes several months and involves several thousand test subjects.
No vaccine data published
The newly approved experimental vaccine was developed by the Moscow Gamaleja Institute and tested for the first time on a few dozen volunteers less than two months ago. So far, no scientific results have been published.
Cichutek criticized this lack of transparency. It is common for vaccine developers to publish initial data through the media or scientific publications – “that has not happened here”.
Despite cooperation with the Russian authorities, the PEI had not heard anything about the far-reaching vaccine development before. The approval does not strengthen the confidence in the Russian drug authorities. “Vaccine development takes time. We need a good database to be able to grant approval with a clear conscience and that is what we will stand for,” said Cichutek.
Ministry of Health: No talks with Russia
Internationally, governments and experts have criticized Russia’s actions. A spokeswoman of the Federal Ministry of Health told the newspapers of the Redaktionsnetzwerk Deutschland that no data are known on the quality, effectiveness and safety of the Russian vaccine.
A positive benefit-risk ratio of the vaccine must be proven before it can be widely used. ” In the EU, patient safety is given “top priority”. The ministry says it is not currently holding talks with Russian authorities on the vaccine.
Criticism from the USA
Warnings about the vaccine also came from the USA. “It doesn’t matter if you’re the first with a vaccine. What matters is to have a vaccine that is safe and effective, for the American people and the people of the world,” said U.S. Secretary of Health and Human Services Alex Azar.
Renowned US physicians have a similar view: “Claims of having a vaccine that can be widely used before testing is problematic at best,” said Anthony Fauci, the top expert on infectious diseases in the US. Lawrence Gostin, an expert on global health laws at Georgetown University in Washington, expressed concern that Russia was skipping important steps in the process and “the resulting vaccine may not only be ineffective, but also unsafe.
Israel is considering
Israel on the other hand showed interest in the Russian vaccine, which is to be marketed internationally under the name “Sputnik V”. Israeli Health Minister Juli Edelstein said that there were already consultations. “If we come to the conclusion that it is a serious product, we will also try to start negotiations,” Edelstein said after a report on the news site “ynet”. But he didn’t want to give anyone any illusions: “The vaccine won’t come tomorrow.”
WHO reminds of international standards
The World Health Organization (WHO) emphasizes that potential vaccines must always pass through all test phases before they are put on the market. “There are established practices and guidelines,” said spokesman Christian Lindmeier. In order for a vaccine to be used in Germany, it must be officially approved. Nationally, the PEI is responsible for this. Alternatively, a central European approval can be granted by the EU Commission. Thi
COVID-19 Cure
Updated: 2025-04-04 Type: Write-up Factial: Undetermined Topics: Covid-19, (Post Id: #17)
Perhaps it makes sense to treat the outlying conditions brought on bu COVID-19
Mainstream scientist are working to defeat the virus with a vaccine, and dismissing the reported treatments (hydroxychloroquine, zinc & azithromycin). Perhaps the treatments are defeating the bacteria that flourishes because of the virus. By defeating the bacteria, the body can defeat the virus in most cases. While nothing is 100% effective, perhaps if treatment starts early, most people will survive and have less illness.
Chloroquine is an antimalarial drug that was developed in 1934. Hydroxychloroquine, an analogue of chloroquine, was developed in 1946 and is used to treat autoimmune diseases, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis. In general, hydroxychloroquine has fewer and less severe toxicities (including less propensity to prolong the QTc interval) and fewer drug-drug interactions than chloroquine. [2]
An epidemiology professor at the Yale School of Public Health said hydroxychloroquine could save 100,000 lives from the coronavirus but added that the controversial anti-malaria drug has instead been used in a “propaganda war.” [1]
“There are many doctors that I’ve gotten hostile remarks about, saying that all the evidence is bad for it, and, in fact, that is not true at all,” Risch said, claiming the medication can be used as a “prophylactic” for front-line workers. [1]
“All the evidence is actually good for it when it is used in outpatient uses. Nevertheless, the only people who actually see that are a whole pile of doctors who are on the front lines treating those patients across the country, and they are the ones who are at risk of being forced not to do it,” Risch said. [1]
The use of hydroxychloroquine for treatment of COVID-19 was not associated with harm or benefit in a large observational study. [2]
Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2, and reported to be efficient in Chinese COV-19 patients. [3]
A French survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in COVID-19 patients and its effect is reinforced by azithromycin. [3]
Note that President Donald Trump does not gain financially by promoting hydroxychloroquine. Trump’s financial stake in these companies is virtually negligible — contained indirectly via mutual funds — and administered through three family trusts he does not control. As a generic drug, hydroxychloroquine is unlikely to provide any one company with significant profits compared to other proprietary drugs. [4]
Reporting against the treatment
A large, retrospective, observational study that evaluated the use of hydroxychloroquine has shown no evidence of benefit in patients with COVID-19. Clinical outcomes in that study included death and the need for mechanical ventilation. Reports have documented serious dysrhythmias in patients with COVID-19 who were treated with chloroquine or hydroxychloroquine, often in combination with azithromycin and other medicines that prolong the QTc interval. Given the risk of dysrhythmias, the Food and Drug Administration (FDA) cautions against the use of chloroquine or hydroxychloroquine for the treatment of COVID-19 outside of a hospital or clinical trial.2 When chloroquine or hydroxychloroquine is used, clinicians should monitor the patient for adverse effects (AEs), especially prolonged QTc interval (AIII). [2]
References:
1 ~ Yale epidemiologist says hydroxychloroquine could save up to 100K lives if used for coronavirus
https://www.washingtonexaminer.com/news/yale-epidemiologist-says-hydroxychloroquine-could-save-up-to-100k-lives-if-used-for-coronavirus
2 ~ Chloroquine or Hydroxychloroquine
https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/chloroquine-or-hydroxychloroquine/
3 ~ Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
https://pubmed.ncbi.nlm.nih.gov/32205204/
4 ~ Does Trump Benefit Financially by Promoting Hydroxychloroquine as COVID-19 Treatment?
https://www.snopes.com/fact-check/trump-profit-hydroxychloroquine/